8 studies found for:    thermodox
Show Display Options
Rank Status Study
1 Recruiting Phase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest Wall
Condition: Breast Cancer
Intervention: Drug: ThermoDox in combination with Microwave Hyperthermia (heat)
2 Completed A Study of ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver
Conditions: Hepatocellular Carcinoma;   Liver Neoplasms
Intervention: Drug: ThermoDox
3 Terminated Phase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC)
Condition: Colon Cancer Liver Metastasis
Interventions: Drug: Lyso-Thermosensitive Liposomal Doxorubicin;   Other: 5% Dextrose Solution;   Drug: ThermoDox
4 Recruiting Targeted Chemotherapy Using Focused Ultrasound for Liver Metastases
Condition: Patients With Liver Metastases From Lung, Breast or Colorectal Primary Tumours.
Intervention: Drug: lyso-thermosensitive liposomal (LTSL) doxorubicin
5 Recruiting Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC)
Condition: Hepatocellular Carcinoma
Interventions: Drug: ThermoDox;   Drug: Dummy infusion
6 Suspended MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases
Conditions: Painful Bone Metastases;   Breast Carcinoma,;   Non-small Cell Lung Cancer,;   Small Cell Lung Cancer,;   Adenocarcinoma
Intervention: Drug: High Intensity Focused Ultrasound (HIFU) in combination with ThermoDox
7 Active, not recruiting Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
Condition: Hepatocellular Carcinoma
Interventions: Drug: ThermoDox;   Drug: 5% Dextrose Solution
8 Terminated Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer
Condition: Breast Cancer
Interventions: Biological: filgrastim;   Biological: pegfilgrastim;   Drug: lyso-thermosensitive liposomal doxorubicin(Thermodox);   Procedure: hyperthermia treatment

Indicates status has not been verified in more than two years